Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Non-cash Items (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Non-cash Items for 12 consecutive years, with $108.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items rose 3347.01% year-over-year to $108.2 million, compared with a TTM value of $108.2 million through Sep 2025, up 3347.01%, and an annual FY2024 reading of $43059.0, changed N/A over the prior year.
  • Non-cash Items was $108.2 million for Q3 2025 at Arcadia Biosciences, down from $261.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $516.4 million in Q4 2024 and bottomed at $25725.0 in Q1 2023.
  • Average Non-cash Items over 5 years is $84.1 million, with a median of $862726.0 recorded in 2022.
  • The sharpest move saw Non-cash Items surged 30483.26% in 2022, then plummeted 99.98% in 2023.
  • Year by year, Non-cash Items stood at $240000.0 in 2021, then skyrocketed by 259.47% to $862726.0 in 2022, then tumbled by 95.9% to $35364.0 in 2023, then skyrocketed by 1460079.84% to $516.4 million in 2024, then plummeted by 79.04% to $108.2 million in 2025.
  • Business Quant data shows Non-cash Items for RKDA at $108.2 million in Q3 2025, $261.6 million in Q2 2025, and $40.8 million in Q1 2025.